These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18616717)

  • 1. Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS).
    Giallauria F; Palomba S; De Sio I; Maresca L; Vuolo L; Savastano S; Lombardi G; Colao A; Vigorito C; Orio F
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):394-400. PubMed ID: 18616717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of inflammation are inversely associated with VO2 max in asymptomatic men.
    Kullo IJ; Khaleghi M; Hensrud DD
    J Appl Physiol (1985); 2007 Apr; 102(4):1374-9. PubMed ID: 17170204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).
    Giallauria F; Palomba S; Maresca L; Vuolo L; Tafuri D; Lombardi G; Colao A; Vigorito C; Francesco O
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):792-8. PubMed ID: 18505468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
    Cascella T; Palomba S; De Sio I; Manguso F; Giallauria F; De Simone B; Tafuri D; Lombardi G; Colao A; Orio F
    Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of hs-CRP and fibrinogen with anthropometric and lipid parameters in non-obese adolescent girls with polycystic ovary syndrome.
    Mažibrada I; Djukić T; Perović S; Plješa-Ercegovac M; Plavšić L; Bojanin D; Bjekić-Macut J; Simić PD; Simić T; Savić-Radojević A; Mastorakos G; Macut D
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1213-1220. PubMed ID: 30335612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
    Jae SY; Heffernan KS; Lee MK; Fernhall B; Park WH
    Am J Cardiol; 2008 Sep; 102(6):700-3. PubMed ID: 18773991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.
    Talbott EO; Zborowski JV; Boudreaux MY; McHugh-Pemu KP; Sutton-Tyrrell K; Guzick DS
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6061-7. PubMed ID: 15579759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL; Stepto NK; Hutchison SK; Teede HJ
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary impairment in young women with polycystic ovary syndrome.
    Orio F; Giallauria F; Palomba S; Cascella T; Manguso F; Vuolo L; Russo T; Tolino A; Lombardi G; Colao A; Vigorito C
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2967-71. PubMed ID: 16757529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed characterisation of circulatory nitric oxide and free radical indices--is there evidence for abnormal cardiovascular homeostasis in young women with polycystic ovary syndrome?
    Willis GR; Udiawar M; Evans WD; Blundell HL; James PE; Rees DA
    BJOG; 2014 Dec; 121(13):1596-603. PubMed ID: 24816317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
    Glintborg D; Sidelmann JJ; Altinok ML; Mumm H; Andersen M
    Metabolism; 2015 Oct; 64(10):1272-8. PubMed ID: 26194691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between arterial elasticity, C-reactive protein and maximal oxygen consumption in well-trained cadets during three days extreme physical load: a pilot study.
    Kampus P; Kals J; Unt E; Zilmer K; Eha J; Teesalu R; Normak A; Zilmer M
    Physiol Meas; 2008 Apr; 29(4):429-37. PubMed ID: 18354247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
    Hu W; Qiao J; Yang Y; Wang L; Li R
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
    Tosi F; Dorizzi R; Castello R; Maffeis C; Spiazzi G; Zoppini G; Muggeo M; Moghetti P
    Eur J Endocrinol; 2009 Nov; 161(5):737-45. PubMed ID: 19713424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M; Aydemir M; Tuzcu A
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory and endothelial markers in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Piperi C; Protogerou A; Katsikis I; Paterakis T; Lekakis J; Panidis D
    Eur J Clin Invest; 2006 Oct; 36(10):691-7. PubMed ID: 16968464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
    Moradi S; Mollabashi M; Kerman SR
    Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease.
    Boulman N; Levy Y; Leiba R; Shachar S; Linn R; Zinder O; Blumenfeld Z
    J Clin Endocrinol Metab; 2004 May; 89(5):2160-5. PubMed ID: 15126536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.